# OXCARBAZEPINE
> **ANDA215726** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-08-30
## Drug
- **FDA Application Number:** ANDA215726
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** OXCARBAZEPINE
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2022-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215726)
---
*MORVS · CC0 1.0*